On 9 February 2023, L’Oréal’s Board of Directors approved two proposed partial asset contributions, which were set to take place on 1 July 2023.
These transactions consisted of:
In April 2023, the Group announced that it had signed an agreement with Natura & Co to acquire Aésop, the Australian luxury cosmetics brand, for €2.4 billion. The acquisition by the subsidiary L’Oréal Australia, wholly owned by L’Oréal S.A., was finalised in August 2023. It was financed in the amount of €0.4 billion by cash held by the Group and a bond issued in May 2023 in the amount of €2 billion in two tranches (see note 18).
Reorganisations of a legal nature were carried out following this acquisition. In November 2023, L’Oréal S.A. acquired 100% of Aésop UK shares from Eméis Holding PTY Ltd for €968.2 million.
In September 2023, L’Oréal sold the Sanoflore brand to Ekkio Capital, a French investment fund specialising in SMEs in the healthcare and beauty sector. The impact of this disposal on L’Oréal S.A.’s income statement was not significant.
In November 2023, the Group issued a further bond for €1.5 billion in two tranches (see note 18).